Topic · page 35 of 47

Lupus & antiphospholipid syndrome

Systemic and cutaneous lupus erythematosus, lupus nephritis, neuropsychiatric lupus, disease activity, remission and low disease activity, damage, antimalarials and targeted treatment; antiphospholipid antibodies and antiphospholipid syndrome, thrombotic and obstetric

Briefs 1,361–1,400 of 1,848 placed here, newest publication first

Briefs in Lupus & antiphospholipid syndrome

Newest publication first

Ann Rheum Dis2 Jan 2024
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
Guideline or statement
Lupus30 Dec 2023
The clinicopathological features and renal prognostic factors in pure membranous lupus nephritis—a large series cohort study from China
Cohort study
Lupus30 Dec 2023
Changes in retinal and choroidal thickness and vascular density in patients with systemic lupus erythematosus: Assessed by optical coherence tomography angiography
Cross-sectional study
Lupus Sci Med28 Dec 2023
Clinical significance of exostosin 1 in confirmed and suspected lupus membranous nephropathy
Cohort study
Rheumatology (Oxford)25 Dec 2023
Efficacy and safety of belimumab in patients with lupus nephritis: a real-world retrospective observational study
Cohort study
Rheumatology (Oxford)23 Dec 2023
Transcriptomic features of systemic lupus erythematosus patients in flare and changes during acute in-hospital treatment
Mechanistic study
Lupus Sci Med22 Dec 2023
Steroid-sparing effect of belimumab: results from a retrospective observational study of real-world data
Cohort study
Lupus Sci Med20 Dec 2023
Burden of systemic lupus erythematosus in clinical practice: baseline data from the SLE Prospective Observational Cohort Study (SPOCS) by interferon gene signature
Cross-sectional study
Lancet Rheumatol20 Dec 2023
Economic insecurities and patient-reported outcomes in patients with systemic lupus erythematosus in the USA: a cross-sectional analysis of data from the California Lupus Epidemiology Study
Cross-sectional study
Lupus20 Dec 2023
Non-invasive prediction of the chronic degree of lupus nephropathy based on ultrasound radiomics
Diagnostic or prognostic study
Semin Arthritis Rheum20 Dec 2023
Thrombosis recurrence and major bleeding in non-anticoagulated thrombotic antiphospholipid syndrome patients: Prospective study from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) clinical database and repository (“Registry”)
Cohort study
Lupus Sci Med19 Dec 2023
Case series of anifrolumab for treatment of cutaneous lupus erythematosus and lupus-related mucocutaneous manifestations in patients with SLE
Cohort study
Rheumatology (Oxford)18 Dec 2023
Attribution of neuropsychiatric symptoms and prioritization of evidence in the diagnosis of neuropsychiatric lupus: mixed methods analysis of patient and clinician perspectives from the international INSPIRE study
Research article
Clin Exp Rheumatol18 Dec 2023
WNT16 as a promising biomarker for systemic lupus erythematosus and its role in regulating cell proliferation and apoptosis
Diagnostic or prognostic study
Lupus Sci Med17 Dec 2023
Development and psychometric evaluation of a physician global assessment for type 2 systemic lupus erythematosus symptoms
Guideline or statement
Semin Arthritis Rheum16 Dec 2023
Predictors and prognostic factors influencing outcomes of anti-CD20 monoclonal antibodies in systemic lupus erythematosus: A systematic review update
Meta-analysis
J Rheumatol15 Dec 2023
Patient and Physician Perspectives of Systemic Lupus Erythematosus Flare: A Qualitative Study
Research article
Lupus11 Dec 2023
Spectrum of initial clinical presentations in Pakistani patients with systemic lupus erythematosus in the Arthritis Care Foundation lupus cohort
Cohort study
Rheumatology (Oxford)11 Dec 2023
Landscape of immune cells in systematic lupus erythematosus patients with Epstein–Barr virus infection: assessed by single-cell sequencing
Mechanistic study
Lupus Sci Med9 Dec 2023
Canadian patient experiences of lupus nephritis: a qualitative analysis
Research article
Rheumatology (Oxford)9 Dec 2023
Cost-of-illness changes before and after the diagnosis of systemic lupus erythematosus: a nationwide, population-based observational study in Korea
Cohort study
Rheumatology (Oxford)9 Dec 2023
The efficacy of rituximab plus belimumab or telitacicept in refractory lupus nephritis
Cohort study
Lupus8 Dec 2023
Immunohistochemical expression of perforin in adult systemic lupus erythematosus associated macrophage activation syndrome: Clinicohematological correlation and literature review
Cross-sectional study
RMD Open6 Dec 2023
Assessment and personalised advice for fatigue in systemic lupus erythematosus using an innovative digital tool: the Lupus Expert system for the Assessment of Fatigue (LEAF) study
Cross-sectional study
Rheumatology (Oxford)6 Dec 2023
Gastrointestinal manifestations in systemic lupus erythematosus: data from an Indian multi-institutional inception (INSPIRE) cohort
Cohort study
Lupus5 Dec 2023
Patients with systemic lupus erythematosus who are underweight have distinct disease characteristics
Cohort study
Lupus4 Dec 2023
Rituximab as add-on therapy in patients with resistant lupus nephritis who have failed induction or maintenance therapy with other agents: A real-world experience from a single center in Mumbai
Cohort study
Lupus4 Dec 2023
Sociodemographic profiles and organ damage accural in the Black Women’s Experience Living with Lupus study
Cohort study
Lupus4 Dec 2023
A qualitative study on opportunities to improve research engagement and inclusion of Black adults with systemic lupus erythematosus
Research article
Rheumatology (Oxford)4 Dec 2023
Systemic lupus erythematosus patients have unique changes in serum metabolic profiles across age associated with cardiometabolic risk
Cross-sectional study
Lupus1 Dec 2023
Cardiovascular disease risk perceptions and influencing factors among Chinese systemic lupus erythematosus patients
Cross-sectional study
Lupus29 Nov 2023
Referral and evaluation for kidney transplantation among patients with lupus nephritis-related end-stage kidney disease
Cohort study
Arthritis Rheumatol29 Nov 2023
Obexelimab in Systemic Lupus Erythematosus With Exploration of Response Based on Gene Pathway Co‐Expression Patterns: A Double‐Blind, Randomized, Placebo‐Controlled, Phase 2 Trial
Randomized controlled trial
Arthritis Care Res (Hoboken)28 Nov 2023
Reference Range of Hydroxychloroquine Blood Levels That Can Reduce Odds of Active Lupus and Prevent Flares
Cohort study
Rheumatology (Oxford)27 Nov 2023
Real-world efficacy of belimumab in systemic lupus erythematosus: a prospective cohort from a single centre in China
Cohort study
RMD Open27 Nov 2023
Cardiovascular risk assessment in patients with antiphospholipid syndrome: a cross-sectional performance analysis of nine clinical risk prediction tools
Cross-sectional study
Lupus Sci Med24 Nov 2023
Efficacy and safety of telitacicept in patients with systemic lupus erythematosus: a multicentre, retrospective, real-world study
Cohort study
Rheumatology (Oxford)24 Nov 2023
Long-term outcomes of lupus nephritis with low-level proteinuria: a multicentre, retrospective study
Cohort study
Rheumatology (Oxford)24 Nov 2023
Multimorbidity in systemic lupus erythematosus in a population-based cohort: the Lupus Midwest Network
Cohort study
RMD Open23 Nov 2023
Development and external validation of a prediction model for venous thromboembolism in systemic lupus erythematosus
Diagnostic or prognostic study

All 1,848 Briefs in ExploreShowing Briefs 1,361–1,400 of 1,848, newest first